#USA #Los Angeles #Schall Law Firm #Securities Fraud #Adverum

Investigation of Adverum Biotechnologies by Schall Law Firm

The Schall Law Firm, a prominent litigation firm focused on shareholder rights, has initiated an investigation into potential securities violations by Adverum Biotechnologies, Inc. This investigation comes on the heels of significant revelations about Adverum's financial reporting, particularly concerning irregularities in accounting practices.

Background on Adverum Biotechnologies

Adverum, a company listed on NASDAQ under the ticker ADVM, has faced scrutiny from its investors after disclosing issues that raised serious questions about the accuracy of its previously reported financial statements. The company revealed on March 31, 2025, that certain financial records were flawed due to non-cash accounting errors associated with tenant improvement allowances linked to an operating lease and sublease for their premises in North Carolina. These errors prompted Adverum to announce a restatement of its financial results for the years ending December 31, 2022, and December 31, 2023, as detailed in the company's Annual Report.

Implications for Investors

The fallout from this announcement was immediate, with Adverum’s stock price plummeting by more than 12% on April 1, 2025. Investors who relied on the accuracy of the financial reports prior to this revelation may have suffered financial losses. As a result, the Schall Law Firm is actively looking for individuals who own shares in Adverum and have experienced a loss due to these questionable disclosures.

What Investors Can Do

Shareholders are encouraged to reach out to the Schall Law Firm to discuss their rights and any potential claims they may hold against the company. Brian Schall, an attorney at the firm, is leading this investigation and offers consultations to assess any losses investors may have incurred. Interested parties can contact him directly at the firm's office in Los Angeles, or through their official website for more details.

The Role of the Schall Law Firm

The Schall Law Firm specializes in class action lawsuits and has a solid track record representing investors in cases of securities fraud. With the current volatility surrounding Adverum Biotechnologies, their representation can provide a crucial avenue for shareholders seeking justice and recovery of losses incurred due to the company's misstatements. This situation underlines the importance of transparency and accountability in corporate governance and financial reporting.

In conclusion, the ongoing investigation by the Schall Law Firm not only highlights potential wrongdoings by Adverum but also serves as a reminder for investors to stay vigilant regarding the accuracy of financial disclosures in the companies they invest in. For further information, shareholders are urged to get in touch with the Schall Law Firm promptly.